Skip to content
Clinical Trials – home

Azienda Sociosanitaria Territoriale Santi Paolo E Carlo

Verifiedinfo

Italy Via Antonio Di Rudini' 8, 20142 Milan, Italy

  • 36 trials recruiting
  • HIV infection · Plasma cell myeloma · Idiopathic pulmonary fibrosis
  • Adults and children

About Specializations

Azienda Sociosanitaria Territoriale Santi Paolo E Carlo in Milan, Italy specialises in clinical trials of conditions such as HIV infection, Plasma cell myeloma, Idiopathic pulmonary fibrosis, Chronic obstructive pulmonary disease, and other specialisations. This site conducts important research.

Main research areas of the site

Virus Diseases and Infectious Disease Research

At Azienda Sociosanitaria Territoriale Santi Paolo E Carlo in Milan, a major share of the clinical research focuses on HIV infections, HIV-1 infection, and mpox virus disease. These studies are designed to assess new antiviral options, improve treatment switching strategies, and better understand outcomes in people living with or newly diagnosed with viral infections.

  • Evaluation of new antiviral therapies for HIV-1
  • Studies on treatment switching and long-term control in HIV
  • Clinical observations in mpox virus disease to guide care

The site’s infectious diseases team is building evidence to support safer, more effective management of viral illnesses in everyday practice.

Respiratory Tract Diseases and Pulmonary Medicine

Research in respiratory diseases includes chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, and progressive pulmonary fibrosis. These trials aim to reduce flare-ups, slow lung function decline, and evaluate whether emerging treatments can improve breathing and quality of life for people with chronic lung disease.

  • Testing therapies for COPD with frequent exacerbations
  • Assessing treatments for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
  • Exploring ways to lower disease burden in long-term lung disease

This area reflects a strong interest in improving outcomes for patients with complex and progressive respiratory conditions.

Eye Diseases and Ophthalmology

The site is also active in ophthalmic research, with studies in glaucoma, neurotrophic keratopathy, and seasonal allergic conjunctivitis. These trials are focused on preserving vision, easing eye symptoms, and evaluating new approaches that may help protect eye health in people with chronic or inflammatory eye disorders.

  • Improving visual field preservation in glaucoma
  • Testing treatments for corneal nerve damage in neurotrophic keratopathy
  • Relieving symptoms of seasonal allergic conjunctivitis

The ophthalmology studies combine symptom control with efforts to maintain long-term vision and eye function.

Cardiovascular Diseases and Acute Care Research

In the cardiovascular field, clinical trials at this site examine heart failure and pulmonary hypertension due to left heart disease, stroke, and the reversal of anticoagulation in urgent surgical settings. The research is aimed at improving survival, reducing complications, and supporting safer treatment decisions in time-sensitive cardiovascular care.

  • Evaluating therapies for heart failure with pulmonary hypertension
  • Studying treatment effectiveness after stroke
  • Improving bleeding control and urgent care for patients on anticoagulants

These studies address both chronic cardiovascular disease and emergency management needs.

Digestive System Diseases and Metabolic-Renal Research

The site’s work in digestive system diseases includes research on cholestasis, while related studies also address chronic kidney disease associated with type 1 diabetes. Together, these trials are examining new ways to reduce symptoms, protect organ function, and improve disease control in patients with long-term metabolic and hepatobiliary conditions.

  • Testing treatments for cholestatic pruritus
  • Evaluating kidney-protective strategies in chronic kidney disease with type 1 diabetes
  • Supporting better management of complex multi-organ disease

At this Milan hospital, the research portfolio shows a broad interest in chronic conditions that affect quality of life and long-term health.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Via Antonio Di Rudini' 820142 MilanItaly
Recruiting now
36 trials
Conditions studied
77
Partner status
Verified

More sites in MilanItaly

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

98 clinical trials

Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Sponsor:Pfizer Inc.

Renal disorder

Recruiting
Investigational
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Sponsor:Newron Pharmaceuticals S.p.A.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Ro7790121
  • Sponsor:F. Hoffmann-La Roche AG
Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Mirikizumab
  • Sponsor:Eli Lilly & Co.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bhv-7000
  • Sponsor:Biohaven Therapeutics Ltd.
Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Clazakizumab
  • Sponsor:CSL Behring LLC
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bms-986340
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cabotegravir
  • Sponsor:Gilead Sciences Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Ntc S.r.l.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Teclistamab
  • Sponsor:Janssen Cilag International
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.